{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_Display\ Name in Display Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
BLA125127
(2005)
Source URL:
First approved in 2005
Source:
BLA125127
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125127
(2005)
Source URL:
First approved in 2005
Source:
BLA125127
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT01659996: Phase 4 Interventional Completed Meningitis
(2012)
Source URL:
First approved in 2005
Source:
BLA125089
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125020
(2003)
Source URL:
First approved in 2003
Source:
BLA125020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125020
(2003)
Source URL:
First approved in 2003
Source:
BLA125020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125020
(2003)
Source URL:
First approved in 2003
Source:
BLA125020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125020
(2003)
Source URL:
First approved in 2003
Source:
BLA125020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125034
(2003)
Source URL:
First approved in 2003
Source:
BLA125034
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03855176: Phase 4 Interventional Completed Hepatitis A
(2017)
Source URL:
First approved in 1996
Source:
BLA103606
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
ANDA212744
(1989)
Source URL:
First approved in 1989
Source:
ANDA212744
Source URL:
Class:
STRUCTURALLY DIVERSE